Baseline characteristics of patients with HCL by treatment group before and after propensity score matching
| Demographic Characteristic . | All patients . | Propensity-matched patients . | |||||
|---|---|---|---|---|---|---|---|
| AS (n = 535) . | No treatment (N = 585) . | Up-front treatment (N = 4230) . | P value . | AS (n = 460) . | Up-front treatment (n = 2300) . | P value . | |
| Age group, n (%) | |||||||
| <60 | 161 (30.1) | 196 (33.5) | 2459 (58.1) | <.001 | 136 (29.6) | 770 (33.5) | .11 |
| ≥60 | 374 (69.9) | 389 (66.5) | 1771 (41.9) | 324 (70.4) | 1530 (66.5) | ||
| Sex, n (%) | |||||||
| Female | 123 (23.0) | 145 (24.8) | 791 (18.7) | .02 | 102 (22.2) | 523 (22.7) | .86 |
| Male | 412 (77.0) | 440 (75.2) | 3439 (81.3) | 358 (77.8) | 1777 (77.3) | ||
| Race, n (%) | |||||||
| White | 500 (93.5) | 529 (90.4) | 3909 (92.4) | .14 | 434 (94.3) | 2152 (93.6) | .93 |
| African American | 12 (2.2) | 30 (5.1) | 145 (3.4) | 9 (2.0) | 59 (2.6) | ||
| Other/Unknown | 23 (4.3) | 26 (4.4) | 156 (3.7) | 17 (3.7) | 89 (3.9) | ||
| Charlson-Deyo score, n (%) | |||||||
| 0 | 454 (84.9) | 478 (81.7) | 3623 (85.7) | .18 | 389 (84.6) | 1947 (84.7) | .94 |
| ≥1 | 81 (15.1) | 107 (18.3) | 607 (14.3) | 71 (15.4) | 353 (15.3) | ||
| Insurance status, n (%) | |||||||
| Private | 240 (44.9) | 225 (38.5) | 2473 (58.4) | <.001 | 205 (44.6) | 1127 (49.0) | .32 |
| Government | 280 (52.3) | 320 (54.7) | 1488 (35.2) | 240 (52.2) | 1089 (47.3) | ||
| Not insured | 5 (0.9) | 26 (4.4) | 173 (4.1) | 5 (1.1) | 30 (1.3) | ||
| Unknown | 10 (1.9) | 14 (2.4) | 96 (2.3) | 10 (2.2) | 54 (2.3) | ||
| Demographic Characteristic . | All patients . | Propensity-matched patients . | |||||
|---|---|---|---|---|---|---|---|
| AS (n = 535) . | No treatment (N = 585) . | Up-front treatment (N = 4230) . | P value . | AS (n = 460) . | Up-front treatment (n = 2300) . | P value . | |
| Age group, n (%) | |||||||
| <60 | 161 (30.1) | 196 (33.5) | 2459 (58.1) | <.001 | 136 (29.6) | 770 (33.5) | .11 |
| ≥60 | 374 (69.9) | 389 (66.5) | 1771 (41.9) | 324 (70.4) | 1530 (66.5) | ||
| Sex, n (%) | |||||||
| Female | 123 (23.0) | 145 (24.8) | 791 (18.7) | .02 | 102 (22.2) | 523 (22.7) | .86 |
| Male | 412 (77.0) | 440 (75.2) | 3439 (81.3) | 358 (77.8) | 1777 (77.3) | ||
| Race, n (%) | |||||||
| White | 500 (93.5) | 529 (90.4) | 3909 (92.4) | .14 | 434 (94.3) | 2152 (93.6) | .93 |
| African American | 12 (2.2) | 30 (5.1) | 145 (3.4) | 9 (2.0) | 59 (2.6) | ||
| Other/Unknown | 23 (4.3) | 26 (4.4) | 156 (3.7) | 17 (3.7) | 89 (3.9) | ||
| Charlson-Deyo score, n (%) | |||||||
| 0 | 454 (84.9) | 478 (81.7) | 3623 (85.7) | .18 | 389 (84.6) | 1947 (84.7) | .94 |
| ≥1 | 81 (15.1) | 107 (18.3) | 607 (14.3) | 71 (15.4) | 353 (15.3) | ||
| Insurance status, n (%) | |||||||
| Private | 240 (44.9) | 225 (38.5) | 2473 (58.4) | <.001 | 205 (44.6) | 1127 (49.0) | .32 |
| Government | 280 (52.3) | 320 (54.7) | 1488 (35.2) | 240 (52.2) | 1089 (47.3) | ||
| Not insured | 5 (0.9) | 26 (4.4) | 173 (4.1) | 5 (1.1) | 30 (1.3) | ||
| Unknown | 10 (1.9) | 14 (2.4) | 96 (2.3) | 10 (2.2) | 54 (2.3) | ||